Community Healthcare Trust (CHCT) director paid 2026 Board retainer in restricted stock

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

GULMI CLAIRE M reported acquisition or exercise transactions in this Form 4 filing.

Community Healthcare Trust Inc director Claire M. Gulmi received an award of 7,661 shares of common stock on May 21, 2026. This was a grant of restricted stock taken in lieu of her 2026 Board cash retainer, with a three-year restriction period.

For 2026, she elected to receive 100% of her Board retainer in restricted stock, and the company granted additional restricted shares equal to 60% of the retainer’s value. The award was valued using a ten-day average share price of $17.23, and her direct holdings following the grant total 71,523.141 shares.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider GULMI CLAIRE M

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	7,661	$17.23	$132K

Holdings After Transaction: Common Stock — 71,523.141 shares (Direct, null)

Footnotes (1)

[object Object]

Key Figures

Restricted shares granted: 7,661 shares Pricing basis: $17.23 per share Post-transaction holdings: 71,523.141 shares +2 more

5 metrics

Restricted shares granted 7,661 shares Restricted stock award for 2026 Board retainer

Pricing basis $17.23 per share Ten-day average stock price used to value award

Post-transaction holdings 71,523.141 shares Total common shares directly held after grant

Additional award uplift 60% of Board retainer value Extra restricted stock issued because retainer taken in stock

Restriction period Three years Holding restrictions on the new restricted stock

Key Terms

restricted stock, Board retainer, ten (10) day average stock price, Form 4

4 terms

restricted stock financial

"shares of restricted stock with a three-year restriction period"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Board retainer financial

"take 100% of her Board retainer in the form of shares"

ten (10) day average stock price financial

"based upon the ten (10) day average stock price of the common stock"

Form 4 regulatory

"awarded her additional shares of restricted stock, equal to 60% of the value of the Board retainer"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

05/26/2026 - 05:10 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

GULMI CLAIRE M

(Last)

(First)

(Middle)

3326 ASPEN GROVE DRIVE,

SUITE 150

(Street)

FRANKLIN

TENNESSEE

37067

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Community Healthcare Trust Inc [ CHCT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/21/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	05/21/2026		A		7,661	A	$17.23⁽¹⁾	71,523.141	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. For 2026, the reporting person elected to take 100% of her Board retainer in the form of shares of restricted stock with a three-year restriction period. Because the reporting person elected to take her Board retainer for 2026 in shares of restricted stock in lieu of cash, the Company awarded her additional shares of restricted stock, equal to 60% of the value of the Board retainer. The price of the securities acquired by the reporting person with respect to the Board retainer is based upon the ten (10) day average stock price of the common stock, which is equal to $17.23. The number of securities issued is equal to the total value of the Board retainer plus the value of the additional shares divided by such 10-day average stock price.

Remarks:

	/s/ Nathanael P. Kibler, Attorney-in-fact	05/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did CHCT director Claire M. Gulmi report?

Claire M. Gulmi reported receiving 7,661 shares of Community Healthcare Trust common stock as a grant of restricted stock. The award reflects her 2026 Board retainer taken in stock rather than cash, plus an additional stock component linked to that retainer’s value.

How were the 7,661 CHCT shares for Claire M. Gulmi’s award priced?

The 7,661 restricted shares were valued using a ten-day average stock price of $17.23 per share. The share count equals the total value of her 2026 Board retainer plus the added stock value, divided by that ten-day average price.

Why did Claire M. Gulmi receive additional CHCT restricted shares beyond her Board retainer?

Because she elected to take 100% of her 2026 Board retainer in restricted stock, the company awarded her extra restricted shares equal to 60% of the retainer’s value. This increased the total value of stock she received compared with a cash-only retainer.

What is the restriction period on Claire M. Gulmi’s new CHCT restricted stock?

The restricted stock awarded to Claire M. Gulmi carries a three-year restriction period. During this time, transfer of the shares is limited under the award terms, aligning the director’s compensation more closely with Community Healthcare Trust’s longer-term performance.

How many CHCT shares does Claire M. Gulmi hold after this restricted stock grant?

After receiving the 7,661 restricted shares, Claire M. Gulmi directly holds a total of 71,523.141 Community Healthcare Trust common shares. This figure reflects her updated position following the 2026 Board retainer-related stock award disclosed in the Form 4 filing.

Is Claire M. Gulmi’s CHCT Form 4 transaction an open-market purchase or a compensation grant?

The transaction is a compensation-related grant, not an open-market purchase. It reflects restricted stock issued as her 2026 Board retainer, plus additional shares equal to 60% of the retainer value, all valued using a ten-day average price of $17.23.